Abbott to sell Apricus erectile dysfunction drug in Canada
(Reuters) - Apricus Biosciences Inc said it licensed the Canadian marketing rights of its Erectile Dysfunction drug to Abbott Laboratories for about $16 million, sending its shares up 10 percent. Apricus' drug Vitaros is approved in Canada and the company has also filed for marketing approval of the drug in the United States. In 2010, the erectile dysfunction market in Canada was worth about $180 million, according to IMS Health data. ... read more..
source:http://yhoo.it/xntVjF
No comments:
Post a Comment